Table 2.
Surgical data of SCAI shock stages.
| Variable | Stage C (n = 95) | Stage D (n = 59) | Stage E (n = 66) | Total (n = 220) | p-Value |
|---|---|---|---|---|---|
| Urgency | |||||
| Elective | 48 (51%) | 28 (47%) | 26 (39%) | 102 (46%) | 0.372 |
| Urgent | 25 (26%) | 12 (20%) | 19 (29%) | 56 (25%) | 0.539 |
| Emergent | 20 (21%) | 16 (27%) | 18 (27%) | 54 (25%) | 0.576 |
| Salvage | 2 (2%) | 3 (5%) | 3 (5%) | 8 (4%) | 0.564 |
| EuroSCORE II (%) | 7 (3–14) | 11 (4–19) | 10 (4–18) | 8 (4–17) | 0.166 |
| Low risk, 0–4%, pts. | 30 (32%) | 17 (29%) | 13 (20%) | 60 (27%) | 0.238 |
| Intermediate risk, 4–8%, pts. | 24 (25%) | 9 (15%) | 14 (21%) | 47 (21%) | 0.338 |
| High risk, 8%>, pts. | 41 (43%) | 33 (56%) | 39 (59%) | 113 (51%) | 0.099 |
| Surgery | |||||
| Isolated CABG | 23 (24%) | 12 (20%) | 18 (27%) | 53 (24%) | 0.664 |
| Isolated, non-CABG | 17 (18%) | 18 (31%) | 7 (11%) | 42 (19%) | 0.017 |
| CABG + AVR | 9 (9%) | 1 (2%) | 14 (21%) | 24 (11%) | 0.002 |
| AVR + MVR/P | 3 (3%) | 2 (3%) | 2 (3%) | 7 (3%) | 0.993 |
| Stand-alone and | |||||
| concomitant mixed | |||||
| CABG | 51 (54%) | 24 (41%) | 41 (53%) | 116 (53%) | 0.055 |
| AVR | 26 (27%) | 18 (31%) | 21 (32%) | 65 (30%) | 0.816 |
| MVR/P | 31 (33%) | 21 (36%) | 16 (24%) | 68 (31%) | 0.348 |
| Valves | 52 (55%) | 34 (58%) | 38 (58%) | 124 (56%) | 0.914 |
| Aortic | 27 (28%) | 15 (25%) | 12 (18%) | 54 (25%) | 0.327 |
Note: Values are the median (IQL: interquartile range) or n (%). Statistical significance was determined at the p < 0.05 level. EuroSCORE II, European System for Cardiac Operative Risk Evaluation; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; MVR/P, mitral valve replacement/plasty.